229 related articles for article (PubMed ID: 8504270)
1. High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD.
de Bueger M; Bakker A; Bontkes H; van Rood JJ; Goulmy E
Bone Marrow Transplant; 1993 May; 11(5):363-8. PubMed ID: 8504270
[TBL] [Abstract][Full Text] [Related]
2. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
3. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
4. [Frequency of cytotoxic and helper T-lymphocyte precursors in donors with alloreactivity to recipient histocompatibility antigens. Possible use in predicting acute graft vs host disease in bone marrow transplantation].
Cukrová V; Dolezalová L; Loudová M; Vítek A; Starý J
Cas Lek Cesk; 1997 Feb; 136(3):80-4. PubMed ID: 9221174
[TBL] [Abstract][Full Text] [Related]
5. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
[TBL] [Abstract][Full Text] [Related]
6. Frequency analysis of cytotoxic T lymphocyte precursors in search for donors in bone marrow transplantation.
Cukrová V; Dolezalová L; Loudová M; Matĕjková E; Korínková P; Lukásová M; Starý J
Neoplasma; 1995; 42(1):3-8. PubMed ID: 7617071
[TBL] [Abstract][Full Text] [Related]
7. Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT.
van der Meer A; Allebes WA; Voorter CE; van den Berg-Loonen EM; Schattenberg AV; de Witte TJ; Joosten I
Bone Marrow Transplant; 1998 Dec; 22(11):1049-55. PubMed ID: 9877266
[TBL] [Abstract][Full Text] [Related]
8. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
[TBL] [Abstract][Full Text] [Related]
9. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg JH; Vossen J; Gratwohl A; Vogelsang GB; van Houwelingen HC; van Rood JJ
N Engl J Med; 1996 Feb; 334(5):281-5. PubMed ID: 8532022
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocyte precursor frequency as a predictor of acute graft-versus-host disease in bone marrow transplantation from HLA-identical siblings.
Affaticati P; Locatelli F; Roggero S; Marmont F; Falda M; Dall'Omo AM; Busca A; Ceretto C; Praticò L; Berrino M; Curtoni ES
Bone Marrow Transplant; 2000 Sep; 26(5):517-23. PubMed ID: 11019841
[TBL] [Abstract][Full Text] [Related]
11. No predictive value of cytotoxic or helper T-cell precursor frequencies for outcome when analyzed from the graft after stem cell transplantation.
Kircher B; Niederwieser D; Gächter A; Lätzer K; Eibl G; Gastl G; Nachbaur D
Ann Hematol; 2004 Sep; 83(9):566-72. PubMed ID: 15170521
[TBL] [Abstract][Full Text] [Related]
12. Measurement of recipient-specific alloreactivity: is GVHD predictable?
Theobald M; Bunjes D; Nierle T; Arnold R; Heimpel H
Bone Marrow Transplant; 1993; 12 Suppl 3():S18-23. PubMed ID: 8124251
[TBL] [Abstract][Full Text] [Related]
13. Predicting graft-versus-host disease in HLA-identical bone marrow transplant: a comparison of T-cell frequency analysis and a human skin explant model.
Dickinson AM; Sviland L; Wang XN; Jackson G; Taylor PR; Dunn A; Proctor SJ
Transplantation; 1998 Oct; 66(7):857-63. PubMed ID: 9798694
[TBL] [Abstract][Full Text] [Related]
14. Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells.
Jiang YZ; Kanfer EJ; Macdonald D; Cullis JO; Goldman JM; Barrett AJ
Bone Marrow Transplant; 1991 Oct; 8(4):253-8. PubMed ID: 1756322
[TBL] [Abstract][Full Text] [Related]
15. Frequency of bone marrow T cells responding to HLA-identical non-leukemic and leukemic stimulator cells.
Hoffmann T; Theobald M; Bunjes D; Weiss M; Heimpel H; Heit W
Bone Marrow Transplant; 1993 Jul; 12(1):1-8. PubMed ID: 8374531
[TBL] [Abstract][Full Text] [Related]
16. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
[TBL] [Abstract][Full Text] [Related]
17. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation.
Kaminski E; Hows J; Man S; Brookes P; Mackinnon S; Hughes T; Avakian O; Goldman JM; Batchelor JR
Transplantation; 1989 Oct; 48(4):608-13. PubMed ID: 2508280
[TBL] [Abstract][Full Text] [Related]
18. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
[TBL] [Abstract][Full Text] [Related]
19. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
[TBL] [Abstract][Full Text] [Related]
20. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
